Skip to main content

Drug Excretion

  • Chapter
  • First Online:
ADME Processes in Pharmaceutical Sciences

Abstract

Drug excretion involves processes responsible of physically removing a drug from the body, either unchanged or in the form of biotransformation products. The main routes for drug excretion are the urine and the bile. Renal excretion plays an important role in eliminating unchanged drugs or their metabolites into urine. A major characteristic of compounds excreted in urine is that they are polar (e. g., ionized). Hydrophobic drugs require previous metabolism (phase I and/or phase II biotransformation reactions) to enhance their excretion by the kidneys. Drugs entering the hepatic circulation may also enter the bile and be excreted into the duodenum and small intestines. Depending on the chemical properties of the drug, it may then be reabsorbed from the small intestine and recirculate (enterohepatic recycling). Those drugs or drug metabolites that are not reabsorbed will pass through the large intestines and be excreted in the feces. In some cases, drugs will be also excreted through the lungs (volatile drugs or metabolites) and sweat. While they are not “intended” excretion routes, drugs might also be excreted through milk, tears, semen, hair, and saliva.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Choi HS, Liu W, Misra P et al (2007) Renal clearance of nanoparticles. Nat Biotechnol 25:1165–1170

    Article  CAS  Google Scholar 

  • Duconge J (2008) Applying organ clearance concepts in a clinical setting. Am J Pharm Educ 72:121

    Article  Google Scholar 

  • Franz T, Scheufler F, Stein K et al (2018) Determination of hydroxy metabolites of cocaine from hair samples and comparison with street cocaine samples. Forensic Sci Int 288:223–226

    Article  CAS  Google Scholar 

  • Haraldsson B, Nyström J, Deen WM (2008) Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 88:451–487

    Article  CAS  Google Scholar 

  • Izzedine H, Perazella MA (2017) Anticancer drug-induced acute kidney injury. Kidney Int Rep 2:504–514

    Article  Google Scholar 

  • Kapusta D (2008) In: Enna SJ, Bylund DB (eds) Drug excretion. Elsevier, Amsterdam

    Google Scholar 

  • Kwon Y (2002) Handbook of essential pharmacokinetics, pharmacodynamics and drug metabolism for industrial scientists. Kluwer Academic Publishers, New York

    Google Scholar 

  • McElnay JC (1996) Drug interactions at plasma and tissue binding sites. In: D’Arcy PF, McElnay JC, Welling PG (eds) Handbook of experimental pharmacology. Springer, Berlin

    Google Scholar 

  • Neri M, Villa G, Garzotto F et al (2016) Nomenclature for renal replacement therapy in acute kidney injury: basic principles. Crit Care 20:318

    Article  Google Scholar 

  • Novaes SF, Schreiner LL, Pereira e Silva I et al (2017) Residues of veterinary drugs in milk in Brazil. Cienc Rural 47:e20170215

    Article  Google Scholar 

  • Pazhayattil GS, Shirali AC (2014) Drug-induced impairment of renal function. Int J Nephrol Renovasc Dis 7:457–468

    PubMed  PubMed Central  Google Scholar 

  • Resiser J, Altintas MM (2016) Podocytes [version 1; referees: 2 approved]. F1000Research 5: 114

    Google Scholar 

  • Roberts MS, Magnusson BM, Burczynski FJ et al (2002) Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Clin Pharmacokinet 41:751–790

    Article  CAS  Google Scholar 

  • Rowland M, Benet LZ, Graham GG (1973) Clearance concepts in pharmacokinetics. J Pharmacokinet Biopharm 1:123–135

    Article  CAS  Google Scholar 

  • Ruiz ME, Conforti P, al FP (2010) The use of saliva as a biological fluid in relative bioavailability studies: comparison and correlation with plasma results. Biopharm Drug Dispos 31:476–485

    Article  CAS  Google Scholar 

  • Sachs HC (2018) The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics 132:e796–e809

    Article  Google Scholar 

  • Silber TJ (1983) Apparent antibiotic oral contraceptive administration. J Adolesc Health Care 4:287–289

    Article  CAS  Google Scholar 

  • Taft DR (2009) Drug excretion. In: Hacker M, Bachmann K, Messer W (eds).Academic Press, Burlington

    Google Scholar 

  • Testa B, Krämer SD (2006) The biochemistry of drug metabolism – an introduction. Part 1. Principles and overview. Chem Biodivers 3:1053–1101

    Article  CAS  Google Scholar 

  • Wilkinson GR, Shand DG (1975) Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18:377–390

    Article  CAS  Google Scholar 

Further Reading

  • The reader is advised to complement this chapter with Chap. 14 of this volume

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alan Talevi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Talevi, A., Bellera, C.L. (2018). Drug Excretion. In: Talevi, A., Quiroga, P. (eds) ADME Processes in Pharmaceutical Sciences. Springer, Cham. https://doi.org/10.1007/978-3-319-99593-9_5

Download citation

Publish with us

Policies and ethics